|
[1]QAMAR A, VADUGANATHAN M, GREENBERGER NJ, et al.Oral anticoagulation in patients with liver disease[J].J Am Coll Cardiol, 2018, 71 (19) :2162-2175.
|
|
[2]LESURTEL M, GRAF R, ALEIL B, et al.Platelet-derived serotonin mediates liver regeneration[J].Science, 2006, 312 (5770) :104-107.
|
|
[3]ARMANDO T.Hemostasis abnormalities in cirrhosis[J].Curr Opin Hematol, 2015, 22 (5) :406-412.
|
|
[4]LI JT, ZHANG ML.Clinical analysis of 2 cases of liver cirrhosis complicated with venous thrombosis of lower extremity[J].Chin JMed Offic, 2018, 46 (3) :376. (in Chinese) 李军婷, 张美琳.肝硬化并下肢静脉血栓形成2例临床分析[J].临床军医杂志, 2018, 46 (3) :376.
|
|
[5]PECK-RADOSACLIEVIC M.Thrombocytopenia in liver disease[J].Can J Gastroenterol, 2000, 14 (Suppl D) :60D-66D.
|
|
[6]KAJIHARA M, OKAZAKI Y, KATO S, et al.Evaluation of platelet kinetics in patients with liver cirrhosis:Similarity to idiopathic thrombocytopenic purpura[J].J Gastroenterol Hepatol, 2007, 22:112-118.
|
|
[7]MEYER J, LEJMI E, FONTANA P, et al.A focus on the role of platelets in liver regeneration:Do platelet-endothelial cell interactions initiate the regenerative process?[J].J Hepatol, 2015, 63 (5) :1263-1271.
|
|
[8]MATTHEW M, YASUKO I.Biology of portal hypertension[J].Hepatol Int, 2018, 12 (Suppl 1) :11-23.
|
|
[9]REIICHIRO K, HIROHISA Y, OSAMU N, et al.Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C[J].JGastroenterol, 2013, 48 (4) :526-534.
|
|
[10]YOSHIDA S, IKENAGA N, LIU SB, et al.Extrahepatic plateletderived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice[J].Gastroenterology, 2014, 147 (6) :1378-1392.
|
|
[11]KARL E, AUDREY D, EIMEAR D, et al.Increased soluble GPVIlevels in cirrhosis:Evidence for early in vivo platelet activation[J].J Thromb Thrombolysis, 2017, 43 (1) :54-59.
|
|
[12]QUENTIN M, ANSTEE, AMEET D, et al.The role of hypercoagulability in liver fibrogenesis[J].Clin Res Hepatol Gastroenterol, 2011, 35 (8-9) :526-533.
|
|
[13]TRIPODI A, PRIMIGNANI M, MANNUCCI PM, et al.Changing concepts of cirrhotic coagulopathy[J].Am J Gastroenterol, 2017, 112 (2) :274-281.
|
|
[14]BINTA S, GAURANG S.AntifIbrotic effect of heparin on liver fbrosis model in rats[J].World J Gastrointest Pharmacol Ther, 2012, 3 (6) :86-92.
|
|
[15]LI CJ, YANG ZH, SHI XL, et al.Effects of aspirin and enoxaparin in a rat model of liver fibrosis[J].World J Gastroenterol, 2017, 23 (35) :6412-6419.
|
|
[16]JIANG ZG, FELDBRUGGE L, TAPPER EB, et al.Aspirin use is associated with lower indices of liver fibrosis among adults in the U-nited States[J].Aliment Pharmacol Ther, 2016, 43 (6) :734-743.
|
|
[17]AMELLE PR, PIERRE-YVES B, FILOMENA C, et al.Aspirin may reduce liver fibrosis progression:Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation[J].Clin Res Hepatol Gastroenterol, 2014, 38 (5) :570-576.
|
|
[18]SUN YP, GUO XX.Clinical effect of probiotics in treatment of liver cirrhosis:A Meta-analysis[J].J Clin Hepatol, 2018, 34 (1) :73-79. (in Chinese) 孙元培, 郭晓霞.微生态制剂治疗肝硬化的Meta分析[J].临床肝胆病杂志, 2018, 34 (1) :73-79.
|
DownLoad: